# OnCo record bexarotene (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bexarotene/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bexarotene" ;
  schema:name "Bexarotene"@en ;
  schema:description "Bexarotene (Targretin) is a vitamin A-like capsule and gel for the skin disease of cutaneous T-cell lymphoma when other treatments have stopped working."@en ;
  schema:url <https://onco.cc/drugs/bexarotene/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bexarotene> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=bexarotene>, <https://www.cancer.gov/about-cancer/treatment/drugs/bexarotene>, <https://www.ema.europa.eu/en/medicines/human/EPAR/targretin> ;
  onco:status "approved" ;
  onco:tag "nci-list" ;
  onco:modality "Small-molecule retinoid X receptor agonist" ;
  schema:alternateName "Targretin" ;
  onco:approval "US 1999: Cutaneous manifestations of cutaneous T-cell lymphoma refractory to at least one systemic therapy", "EU 2001: Skin manifestations of advanced-stage CTCL refractory to at least one systemic treatment" ;
  onco:targets <https://onco.cc/targets/rxr/> ;
  onco:companies <https://onco.cc/companies/bausch-health/> .